BIO
Price
$298.80
Change
+$5.13 (+1.75%)
Updated
Aug 29, 01:49 PM (EDT)
Capitalization
7.77B
55 days until earnings call
RGEN
Price
$123.30
Change
+$1.13 (+0.92%)
Updated
Aug 29, 01:15 PM (EDT)
Capitalization
6.87B
67 days until earnings call
Interact to see
Advertisement

BIO vs RGEN

Header iconBIO vs RGEN Comparison
Open Charts BIO vs RGENBanner chart's image
Bio-Rad Laboratories
Price$298.80
Change+$5.13 (+1.75%)
Volume$100
Capitalization7.77B
Repligen
Price$123.30
Change+$1.13 (+0.92%)
Volume$427
Capitalization6.87B
BIO vs RGEN Comparison Chart in %
Loading...
BIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BIO vs. RGEN commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIO is a Buy and RGEN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (BIO: $293.67 vs. RGEN: $122.17)
Brand notoriety: BIO and RGEN are both not notable
BIO represents the Medical/Nursing Services, while RGEN is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: BIO: 68% vs. RGEN: 143%
Market capitalization -- BIO: $7.77B vs. RGEN: $6.87B
BIO [@Medical/Nursing Services] is valued at $7.77B. RGEN’s [@Pharmaceuticals: Other] market capitalization is $6.87B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $228.64B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $169.86B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.64B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIO’s FA Score shows that 0 FA rating(s) are green whileRGEN’s FA Score has 0 green FA rating(s).

  • BIO’s FA Score: 0 green, 5 red.
  • RGEN’s FA Score: 0 green, 5 red.
According to our system of comparison, BIO is a better buy in the long-term than RGEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIO’s TA Score shows that 4 TA indicator(s) are bullish while RGEN’s TA Score has 5 bullish TA indicator(s).

  • BIO’s TA Score: 4 bullish, 4 bearish.
  • RGEN’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, RGEN is a better buy in the short-term than BIO.

Price Growth

BIO (@Medical/Nursing Services) experienced а +3.03% price change this week, while RGEN (@Pharmaceuticals: Other) price change was +2.11% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.80%. For the same industry, the average monthly price growth was +6.82%, and the average quarterly price growth was +10.28%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.73%. For the same industry, the average monthly price growth was +6.06%, and the average quarterly price growth was +15.03%.

Reported Earning Dates

BIO is expected to report earnings on Oct 23, 2025.

RGEN is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Medical/Nursing Services (+0.80% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (+0.73% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BIO($7.77B) has a higher market cap than RGEN($6.87B). RGEN has higher P/E ratio than BIO: RGEN (511.11) vs BIO (26.48). BIO YTD gains are higher at: -10.605 vs. RGEN (-15.124). BIO has higher annual earnings (EBITDA): 656M vs. RGEN (99.5M). BIO has more cash in the bank: 1.37B vs. RGEN (709M). RGEN has less debt than BIO: RGEN (686M) vs BIO (1.41B). BIO has higher revenues than RGEN: BIO (2.55B) vs RGEN (674M).
BIORGENBIO / RGEN
Capitalization7.77B6.87B113%
EBITDA656M99.5M659%
Gain YTD-10.605-15.12470%
P/E Ratio26.48511.115%
Revenue2.55B674M379%
Total Cash1.37B709M194%
Total Debt1.41B686M205%
FUNDAMENTALS RATINGS
BIO vs RGEN: Fundamental Ratings
BIO
RGEN
OUTLOOK RATING
1..100
6654
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
95
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
4478
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BIO's Valuation (82) in the Medical Specialties industry is in the same range as RGEN (95) in the Biotechnology industry. This means that BIO’s stock grew similarly to RGEN’s over the last 12 months.

BIO's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as RGEN (100) in the Biotechnology industry. This means that BIO’s stock grew similarly to RGEN’s over the last 12 months.

BIO's SMR Rating (100) in the Medical Specialties industry is in the same range as RGEN (100) in the Biotechnology industry. This means that BIO’s stock grew similarly to RGEN’s over the last 12 months.

BIO's Price Growth Rating (44) in the Medical Specialties industry is somewhat better than the same rating for RGEN (78) in the Biotechnology industry. This means that BIO’s stock grew somewhat faster than RGEN’s over the last 12 months.

BIO's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as RGEN (100) in the Biotechnology industry. This means that BIO’s stock grew similarly to RGEN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BIORGEN
RSI
ODDS (%)
Bearish Trend 1 day ago
65%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
69%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
72%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
74%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
69%
Bearish Trend 1 day ago
79%
Advances
ODDS (%)
Bullish Trend 16 days ago
69%
Bullish Trend 17 days ago
75%
Declines
ODDS (%)
Bearish Trend 3 days ago
66%
Bearish Trend 3 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
79%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
65%
Bearish Trend 1 day ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
BIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CWICX72.640.35
+0.48%
American Funds Capital World Gr&Inc 529C
BARAX93.630.07
+0.07%
Baron Asset Retail
NINAX22.64N/A
N/A
Neuberger Berman Intrinsic Value A
MSEEX24.16N/A
N/A
Morgan Stanley Europe Opportunity C
DTEYX88.85N/A
N/A
BNY Mellon Technology Growth Y